Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
- 2021 (22) (remove)
Document Type
- Journal article (16)
- Doctoral Thesis (5)
- Other (1)
Keywords
- ADHD (2)
- Substantia nigra (2)
- Tourette syndrome (2)
- attention-deficit/hyperactivity disorder (ADHD) (2)
- coercive measures (2)
- employee stress (2)
- residential institutions (2)
- 1p36 deletion syndrome (1)
- 22q11.2 deletion syndrome (1)
- ADHS (1)
- Adoleszenz (1)
- Angstintensität (1)
- Angstsensitivität (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Big Five (1)
- Bruxismus (1)
- CDH13 (1)
- Children (1)
- DBT (1)
- EPMS (1)
- ESCAlife (1)
- Elterntraining (1)
- Erratum (1)
- Extrapyramidales System (1)
- FIQ (1)
- Fragebogen (1)
- Geistige Behinderung (1)
- Heimeinrichtungen (1)
- Juvenile Psychose (1)
- Medizinisches Aufklärungsgespräch (1)
- Mitarbeiterbelastung (1)
- Patientenzufriedenheit (1)
- Schizophrenie (1)
- Schlafbruxismus (1)
- Substantia Nigra - Echogenität (1)
- TCS (1)
- Transkranielle Sonographie (1)
- Transkranieller Ultraschall (1)
- Ultraschalldiagnostik (1)
- actigraphy (1)
- adolescence (1)
- adolescents (1)
- agreeableness (1)
- anorexia nervosa (1)
- anxiety intensity (1)
- anxiety sensitivity (1)
- artifacts (1)
- attention deficit/hyperactivity disorder (1)
- behavior problems (1)
- biomarkers (1)
- case report (1)
- challenging behavior (1)
- challenging behaviours (1)
- children (1)
- chronotype (1)
- classical conditioning (1)
- comparative genomics (1)
- congenital heart-deffects (1)
- continuous performance task (CPT) (1)
- coping strategies (1)
- copy-number variation (1)
- data quality (1)
- dental development in children (1)
- depressive symptoms (1)
- developmental disabilities (1)
- digital phenotyping (1)
- discrimination training (1)
- eating disorders (1)
- ecological momentary assessment (1)
- electroencephalography (EEG) (1)
- executive functions (1)
- fear generalization (1)
- fear-relevant training (1)
- feedback (1)
- freiheitsentziehende Maßnahmen (1)
- guidelines & recommendations (1)
- herausforderndes Verhalten (1)
- intellectual disabilities (1)
- intellectual disability (1)
- intra-individual variability (IIV) (1)
- kindliche Zahnentwicklung (1)
- longitudinal studies (1)
- longitudinal study (1)
- maternal stress (1)
- melatonin (1)
- meta-analysis (1)
- methylphenidate (1)
- minimum reporting standards (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular neuroscience (1)
- multicenter study (1)
- neurodevelopment (1)
- off label use (1)
- oppositional-defiant disorder (1)
- paediatrics (1)
- parent-child interaction therapy (PCIT) (1)
- patient satisfaction (1)
- pharmacokinetics (1)
- precursor symptoms (1)
- psychische Belastung (1)
- psychological distress (1)
- review (1)
- satisfaction with life (1)
- serum concentration (1)
- sleep (1)
- sleep bruxism (1)
- supplements (1)
- tetrahydroisoquinoline derivates (1)
- therapeutic drug monitoring (1)
- third-wave psychotherapy (1)
- tics (1)
- transcranial sonography (1)
- transcutaneous auricular vagus nerve stimulation (1)
- transcutaneous cervical vagus nerve stimulation (1)
- transcutaneous vagus nerve stimulation (1)
- transporter gene SLC2A3 (1)
- vitamin D (1)
- working memory (1)
Institute
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (22) (remove)
Purpose
Tiapride is commonly used in Europe for the treatment of tics. The aim of this study was to examine the relationship between dose and serum concentrations of tiapride and potential influential pharmacokinetic factors in children and adolescents. In addition, a preliminary therapeutic reference range for children and adolescents with tics treated with tiapride was calculated.
Methods
Children and adolescents treated with tiapride at three university hospitals and two departments of child and adolescents psychiatry in Germany and Austria were included in the study. Patient characteristics, doses, serum concentrations, and therapeutic outcome were assessed during clinical routine care using standardised measures.
Results
In the 49 paediatric patients (83.7% male, mean age = 12.5 years), a positive correlation was found between tiapride dose (median 6.9 mg/kg, range 0.97–19.35) and serum concentration with marked inter-individual variability. The variation in dose explained 57% of the inter-patient variability in tiapride serum concentrations; age, gender, and concomitant medication did not contribute to the variability. The symptoms improved in 83.3% of the patients. 27.1% of the patients had mild or moderate ADRs. No patient suffered from severe ADRs.
Conclusions
This study shows that tiapride treatment was effective and safe in most patients with tics. Compared with the therapeutic concentration range established for adults with Chorea Huntington, our data hinted at a lower lower limit (560 ng/ml) and similar upper limit (2000 ng/ml).